MXPA02003977A - Inhibidores de adhesion de celula mediada por al°2. - Google Patents

Inhibidores de adhesion de celula mediada por al°2.

Info

Publication number: MXPA02003977A
Authority: MX; Mexico
Prior art keywords: agr; inhibitors; compound; formula; pharmaceutically acceptable
Prior art date: 1999-10-20

Application number

MXPA02003977A

Other languages

English (en)

Inventor

Ronald C Griffith

Original Assignee

Tanabe Seiyaku Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-20

Filing date

2000-10-19

Publication date

2003-09-25

2000-10-19 Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co

2003-09-25 Publication of MXPA02003977A publication Critical patent/MXPA02003977A/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Hematology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

MXPA02003977A 1999-10-20 2000-10-19 Inhibidores de adhesion de celula mediada por al°2. MXPA02003977A (es)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US16062999P	1999-10-20	1999-10-20
US20984700P	2000-06-07	2000-06-07
PCT/US2000/029273 WO2001030781A2 (en)	1999-10-20	2000-10-19	INHIBITORS OF αLβ2 MEDIATED CELL ADHESION

Publications (1)

Publication Number	Publication Date
MXPA02003977A true MXPA02003977A (es)	2003-09-25

Family

ID=26857065

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA02003977A MXPA02003977A (es)	1999-10-20	2000-10-19	Inhibidores de adhesion de celula mediada por al°2.

Country Status (15)

Country	Link
EP (1)	EP1307455B1 (es)
JP (1)	JP3943394B2 (es)
KR (1)	KR100496940B1 (es)
CN (2)	CN1185232C (es)
AT (1)	ATE292634T1 (es)
AU (1)	AU778757B2 (es)
BR (1)	BR0014651A (es)
CA (1)	CA2388639C (es)
DE (1)	DE60019347T2 (es)
ES (1)	ES2240201T3 (es)
IL (2)	IL148932A0 (es)
MX (1)	MXPA02003977A (es)
NZ (1)	NZ518369A (es)
PT (1)	PT1307455E (es)
WO (1)	WO2001030781A2 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1185232C (zh) *	1999-10-20	2005-01-19	田边制药株式会社	αLβ2介导细胞粘连抑制剂
US7001911B2 (en)	2000-06-28	2006-02-21	Bristol-Myers Squibb Company	Fused cyclic modulators of nuclear hormone receptor function
BR0111298A (pt)	2000-06-28	2005-05-10	Bristol Myers Squibb Co	Moduladores seletivos dos receptores de andrógenos e métodos para identificação, projeto e uso dos mesmos
US20040077605A1 (en)	2001-06-20	2004-04-22	Salvati Mark E.	Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
EP1301512A2 (en) *	2000-07-21	2003-04-16	LION Bioscience AG	Bicyclic hydantoin derivatives and combinatorial libraries thereof
US6953679B2 (en)	2000-09-19	2005-10-11	Bristol-Myers Squibb Company	Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
US6710064B2 (en)	2000-12-01	2004-03-23	Bristol-Myers Squibb Co.	Hydantoin compounds useful as anti-inflammatory agents
WO2002092606A1 (en) *	2001-05-15	2002-11-21	Takeda Chemical Industries, Ltd.	Fused imidazolidine derivatives, process for preparation of the same and use thereof
EP1414795A4 (en)	2001-07-31	2006-03-01	Bristol Myers Squibb Co	BICYCLIC MODULATORS OF THE FUNCTION OF THE ANDROGEN RECEPTOR
AU2002364082A1 (en)	2001-12-19	2003-07-09	Bristol-Myers Squibb Company	Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
TW200303200A (en) *	2002-02-07	2003-09-01	Tanabe Seiyaku Co	Inhibitors of α L β 2 integrin mediated cell adhesion
US7405234B2 (en)	2002-05-17	2008-07-29	Bristol-Myers Squibb Company	Bicyclic modulators of androgen receptor function
TW200407324A (en) *	2002-05-17	2004-05-16	Bristol Myers Squibb Co	Bicyclic modulators of androgen receptor function
JP4617449B2 (ja)	2002-07-11	2011-01-26	ヴィキュロンファーマシューティカルズインコーポレイテッド	抗菌活性を有するｎ−ヒドロキシアミド誘導体
US6974815B2 (en)	2002-10-11	2005-12-13	Bristol-Myers Squibb Company	Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
EP1567487A4 (en) *	2002-11-15	2005-11-16	Bristol Myers Squibb Co	OPEN-CHAINED, PROLYL-FROSTED MODULATORS OF ANDROGEN RECEPTOR FUNCTION
WO2004063181A1 (en) *	2003-01-03	2004-07-29	Genzyme Corporation	Urea derivatives and their use as anti-inflammatory agents
BRPI0409655B8 (pt) *	2003-04-22	2021-05-25	Anormed Inc	compostos heterocíclicos de ligação ao receptor para quimiocina com maior eficiência
US7199125B2 (en)	2003-10-02	2007-04-03	Bristol-Myers Squibb Company	Spiro-cyclic compounds useful as anti-inflammatory agents
US7820702B2 (en)	2004-02-04	2010-10-26	Bristol-Myers Squibb Company	Sulfonylpyrrolidine modulators of androgen receptor function and method
US7696241B2 (en)	2004-03-04	2010-04-13	Bristol-Myers Squibb Company	Bicyclic compounds as modulators of androgen receptor function and method
US7625923B2 (en)	2004-03-04	2009-12-01	Bristol-Myers Squibb Company	Bicyclic modulators of androgen receptor function
TW200616634A (en)	2004-10-01	2006-06-01	Bristol Myers Squibb Co	Crystalline forms and process for preparing spiro-hydantoin compounds
US7186727B2 (en)	2004-12-14	2007-03-06	Bristol-Myers Squibb Company	Pyridyl-substituted spiro-hydantoin compounds and use thereof
AU2006247482A1 (en) *	2005-05-13	2006-11-23	Lexicon Pharmaceuticals, Inc.	Multicyclic compounds and methods of their use
BRPI0616870A2 (pt) *	2005-10-06	2011-07-05	Novartis Ag	compostos de tetra-hidro-pirrolizinona farmaceuticamente ativos, bem como composição farmacêutica, combinação e uso dos mesmos
JP5230448B2 (ja)	2006-02-10	2013-07-10	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	選択的アンドローゲン受容体モジュレーターとして有用な新イミダゾロピラゾール誘導体
EP2039695A4 (en)	2006-07-11	2010-09-15	Takeda Pharmaceutical	BICYCLIC HETEROCYLIC COMPOUND AND ITS USE
MY151004A (en)	2007-11-29	2014-03-31	Boehringer Ingelheim Int	Derivatives of 6,7-dihydro-5h-imidazo[1,2-?]imidazole-3-carboxylic acid amides
PL2445909T3 (pl)	2009-06-02	2014-04-30	Boehringer Ingelheim Int	Pochodne amidów kwasu 6,7-dihydro-5H-imidazo[1,2-a]imidazolo-3-karboksylowego
WO2010141330A1 (en)	2009-06-02	2010-12-09	Boehringer Ingelheim International Gmbh	DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
CN103764608B (zh) *	2011-07-22	2016-02-03	贝南蒂乌斯有限公司	用于治疗炎性肠病的茚衍生物
SI2994454T1 (sl) *	2013-12-09	2019-05-31	Unichem Laboratories Limited	Izboljšan postopek za pripravo (3R,4R)-(1-benzil-4-metil piperidin-3-il)-metil amina
CN106588926B (zh) *	2016-12-28	2018-10-09	华东师范大学	一种2,7-二氮杂[3,2,1]二环辛烷及其衍生物及其合成方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69824183T2 (de) *	1997-08-22	2005-04-21	Hoffmann La Roche	N-alkanoylphenylalaninderivate
CN1185232C (zh) *	1999-10-20	2005-01-19	田边制药株式会社	αLβ2介导细胞粘连抑制剂

2000
- 2000-10-19 CN CNB008145814A patent/CN1185232C/zh not_active Expired - Fee Related
- 2000-10-19 NZ NZ518369A patent/NZ518369A/en unknown
- 2000-10-19 BR BR0014651-0A patent/BR0014651A/pt not_active Application Discontinuation
- 2000-10-19 WO PCT/US2000/029273 patent/WO2001030781A2/en not_active Ceased
- 2000-10-19 MX MXPA02003977A patent/MXPA02003977A/es active IP Right Grant
- 2000-10-19 JP JP2001533134A patent/JP3943394B2/ja not_active Expired - Fee Related
- 2000-10-19 DE DE60019347T patent/DE60019347T2/de not_active Expired - Lifetime
- 2000-10-19 CA CA002388639A patent/CA2388639C/en not_active Expired - Fee Related
- 2000-10-19 EP EP00976625A patent/EP1307455B1/en not_active Expired - Lifetime
- 2000-10-19 AU AU14370/01A patent/AU778757B2/en not_active Ceased
- 2000-10-19 AT AT00976625T patent/ATE292634T1/de not_active IP Right Cessation
- 2000-10-19 PT PT00976625T patent/PT1307455E/pt unknown
- 2000-10-19 CN CNB2004100963975A patent/CN1332961C/zh not_active Expired - Fee Related
- 2000-10-19 ES ES00976625T patent/ES2240201T3/es not_active Expired - Lifetime
- 2000-10-19 KR KR10-2002-7004808A patent/KR100496940B1/ko not_active Expired - Fee Related
- 2000-10-19 IL IL14893200A patent/IL148932A0/xx active IP Right Grant
2002
- 2002-03-27 IL IL148932A patent/IL148932A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP1307455B1 (en)	2005-04-06
IL148932A0 (en)	2002-09-12
EP1307455A2 (en)	2003-05-07
DE60019347D1 (de)	2005-05-12
JP3943394B2 (ja)	2007-07-11
CN1185232C (zh)	2005-01-19
WO2001030781A2 (en)	2001-05-03
CN1382143A (zh)	2002-11-27
ES2240201T3 (es)	2005-10-16
CN1332961C (zh)	2007-08-22
DE60019347T2 (de)	2006-03-09
ATE292634T1 (de)	2005-04-15
IL148932A (en)	2006-12-31
KR20020068523A (ko)	2002-08-27
HK1053473A1 (en)	2003-10-24
AU1437001A (en)	2001-05-08
CA2388639A1 (en)	2001-05-03
KR100496940B1 (ko)	2005-06-23
PT1307455E (pt)	2005-06-30
BR0014651A (pt)	2002-06-18
AU778757B2 (en)	2004-12-16
CN1651431A (zh)	2005-08-10
CA2388639C (en)	2007-07-17
NZ518369A (en)	2003-09-26
JP2003512468A (ja)	2003-04-02
WO2001030781A3 (en)	2001-11-22

Publication	Publication Date	Title
MXPA02003977A (es)	2003-09-25	Inhibidores de adhesion de celula mediada por al°2.
YU69902A (sh)	2005-07-19	Novi derivati piperazina
DE69831868D1 (en)	2006-02-23	Antithrombosemittel
GB9914486D0 (en)	1999-08-18	Medicaments
AU2002211216A1 (en)	2002-04-02	Substituted aminopropoxyaryl derivatives useful as agonists for lxr
BG106585A (en)	2003-03-31	Kinase inhibitors as therapeutic agents
DE60336850D1 (en)	2011-06-01	Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
TR200200579T2 (tr)	2002-12-23	Amino-tirazolpiridin türevleri.
IL133623A0 (en)	2001-04-30	Antithrombotic agents
DZ3312A1 (fr)	2001-09-07	Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
IL157254A0 (en)	2004-02-19	N-substituted nonaryl-heterocyclic nmda/mr2b antagonists
YU94103A (sh)	2006-03-03	Novi derivati sulfonske kiseline
CA2469592A1 (en)	2003-06-19	Hiv integrase inhibitors
YU30603A (sh)	2006-05-25	Derivati premošćenog piperazina
BG104447A (en)	2001-01-31	Biphenylamidine derivatives
MXPA04006041A (es)	2004-09-27	Antivirales de piridoquinoxalina.
DE60114640D1 (en)	2005-12-08	Antithrombosemittel
AU6220300A (en)	2001-02-19	Benzofurylpiperazine serotonin agonists
GB0212410D0 (en)	2002-07-10	Organic compounds
DE60216948D1 (en)	2007-02-01	4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
EP1026162A4 (en)	2001-01-17	ANTI-RHUMATISMAL AGENT
GB0130868D0 (en)	2002-02-06	New compounds
WO2004048381A3 (en)	2004-08-05	Pyrazoloazepine compounds as pharmaceutical agents
AP2002002595A0 (en)	2002-09-30	Heterocyclic amide derivatives.
WO2004035031A3 (en)	2004-07-15	Treatment of uveal melanoma

Legal Events

Date	Code	Title	Description
2007-06-21	FG	Grant or registration
2008-10-17	HC	Change of company name or juridical status